PortalPublikationenIdentification of differentially expressed microRNAs in huma...

Identification of differentially expressed microRNAs in human male breast cancer.

Standard

Identification of differentially expressed microRNAs in human male breast cancer. / Lehmann, Ulrich; Streichert, Thomas; Otto, Benjamin; Albat, Cord; Hasemeier, Britta; Christgen, Henriette; Schipper, Elisa; Hille, Ursula; Kreipe, Hans H; Länger, Florian.

in: BMC CANCER, Jahrgang 10, 2010, S. 109.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Lehmann, U, Streichert, T, Otto, B, Albat, C, Hasemeier, B, Christgen, H, Schipper, E, Hille, U, Kreipe, HH & Länger, F 2010, 'Identification of differentially expressed microRNAs in human male breast cancer.', BMC CANCER, Jg. 10, S. 109. https://doi.org/10.1186/1471-2407-10-109

APA

Lehmann, U., Streichert, T., Otto, B., Albat, C., Hasemeier, B., Christgen, H., Schipper, E., Hille, U., Kreipe, H. H., & Länger, F. (2010). Identification of differentially expressed microRNAs in human male breast cancer. BMC CANCER, 10, 109. https://doi.org/10.1186/1471-2407-10-109

Vancouver

Lehmann U, Streichert T, Otto B, Albat C, Hasemeier B, Christgen H et al. Identification of differentially expressed microRNAs in human male breast cancer. BMC CANCER. 2010;10:109. https://doi.org/10.1186/1471-2407-10-109

Bibtex

@article{87f10f6b20d847fc857649e69cfe180a,
title = "Identification of differentially expressed microRNAs in human male breast cancer.",
abstract = "The discovery of small non-coding RNAs and the subsequent analysis of microRNA expression patterns in human cancer specimens have provided completely new insights into cancer biology. Genetic and epigenetic data indicate oncogenic or tumor suppressor function of these pleiotropic regulators. Therefore, many studies analyzed the expression and function of microRNA in human breast cancer, the most frequent malignancy in females. However, nothing is known so far about microRNA expression in male breast cancer, accounting for approximately 1% of all breast cancer cases.",
author = "Ulrich Lehmann and Thomas Streichert and Benjamin Otto and Cord Albat and Britta Hasemeier and Henriette Christgen and Elisa Schipper and Ursula Hille and Kreipe, {Hans H} and Florian L{\"a}nger",
year = "2010",
doi = "10.1186/1471-2407-10-109",
language = "Deutsch",
volume = "10",
pages = "109",
journal = "BMC CANCER",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Identification of differentially expressed microRNAs in human male breast cancer.

AU - Lehmann, Ulrich

AU - Streichert, Thomas

AU - Otto, Benjamin

AU - Albat, Cord

AU - Hasemeier, Britta

AU - Christgen, Henriette

AU - Schipper, Elisa

AU - Hille, Ursula

AU - Kreipe, Hans H

AU - Länger, Florian

PY - 2010

Y1 - 2010

N2 - The discovery of small non-coding RNAs and the subsequent analysis of microRNA expression patterns in human cancer specimens have provided completely new insights into cancer biology. Genetic and epigenetic data indicate oncogenic or tumor suppressor function of these pleiotropic regulators. Therefore, many studies analyzed the expression and function of microRNA in human breast cancer, the most frequent malignancy in females. However, nothing is known so far about microRNA expression in male breast cancer, accounting for approximately 1% of all breast cancer cases.

AB - The discovery of small non-coding RNAs and the subsequent analysis of microRNA expression patterns in human cancer specimens have provided completely new insights into cancer biology. Genetic and epigenetic data indicate oncogenic or tumor suppressor function of these pleiotropic regulators. Therefore, many studies analyzed the expression and function of microRNA in human breast cancer, the most frequent malignancy in females. However, nothing is known so far about microRNA expression in male breast cancer, accounting for approximately 1% of all breast cancer cases.

U2 - 10.1186/1471-2407-10-109

DO - 10.1186/1471-2407-10-109

M3 - SCORING: Zeitschriftenaufsatz

VL - 10

SP - 109

JO - BMC CANCER

JF - BMC CANCER

SN - 1471-2407

ER -